Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01347866
Title Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

Advanced Solid Tumor

Therapies

Gedatolisib

PD-0325901

Irinotecan

Age Groups: senior | adult
Covered Countries USA | ITA | ESP | CAN


No variant requirements are available.